Caligan Partners LP Diversified Active

CIK: 0001727492 · Show all filings

Period: Q4 2022 (Next →)

Filing Date: May 15, 2023

Total Value ($000): $120,160 (100.0% shares, 0.0% debt)

Holdings (11)

LQDA LIQUIDIA CORP 49.0%
Value ($000) $58,882 Shares 9,243,627 Est. Cost $5.37 Unrealized 0.0%
ANIK ANIKA THERAPEUTICS INC 14.6%
Value ($000) $17,514 Shares 591,675 Est. Cost $28.44 Unrealized 0.0%
EOLS EVOLUS INC 10.9%
Value ($000) $13,073 Shares 1,740,700 Est. Cost $7.74 Unrealized 0.0%
ADMA ADMA BIOLOGICS INC 8.6%
Value ($000) $10,383 Shares 2,676,093 Est. Cost $3.08 Unrealized 0.0%
LAB STANDARD BIOTOOLS INC 8.4%
Value ($000) $10,035 Shares 8,576,799 Est. Cost $1.23 Unrealized 0.0%
— VERONA PHARMA PLC 4.0%
Value ($000) $4,783 Shares 183,064 Est. Cost $26.13 Unrealized —
— SOCIETAL CDMO INC 2.0%
Value ($000) $2,389 Shares 1,603,214 Est. Cost $1.49 Unrealized —
EYPT EYEPOINT PHARMACEUTICALS INC 1.3%
Value ($000) $1,524 Shares 435,298 Est. Cost $4.41 Unrealized 0.0%
— ALIMERA SCIENCES INC 1.1%
Value ($000) $1,297 Shares 478,777 Est. Cost $2.71 Unrealized —
JAZZ JAZZ PHARMACEUTICALS PLC 0.1%
Value ($000) $159 Shares 1,000 Est. Cost $146.56 Unrealized 0.0%
AGIO AGIOS PHARMACEUTICALS INC 0.1%
Value ($000) $122 Shares 4,333 Est. Cost $28.18 Unrealized 0.0%